Your browser doesn't support javascript.
loading
Development of a Severity Classification System for Sickle Cell Disease.
Shah, Nirmish; Beenhouwer, David; Broder, Michael S; Bronte-Hall, Lanetta; De Castro, Laura M; Gibbs, Sarah N; Gordeuk, Victor R; Kanter, Julie; Klings, Elizabeth S; Lipato, Thokozeni; Manwani, Deepa; Scullin, Brigid; Yermilov, Irina; Smith, Wally R.
Afiliação
  • Shah N; Department of Medicine, Duke University, Durham, NC, USA.
  • Beenhouwer D; Partnership for Health Analytic Research (PHAR), LLC, Beverly Hills, CA, USA.
  • Broder MS; Partnership for Health Analytic Research (PHAR), LLC, Beverly Hills, CA, USA.
  • Bronte-Hall L; Foundation for Sickle Cell Disease Research, Hollywood, FL, USA.
  • De Castro LM; Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
  • Gibbs SN; Partnership for Health Analytic Research (PHAR), LLC, Beverly Hills, CA, USA.
  • Gordeuk VR; Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA.
  • Kanter J; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Klings ES; Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
  • Lipato T; Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA, USA.
  • Manwani D; Department of Pediatrics, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Scullin B; Department of Medicine, University of North Carolina, Chapel Hill, NC, USA.
  • Yermilov I; Partnership for Health Analytic Research (PHAR), LLC, Beverly Hills, CA, USA.
  • Smith WR; Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA, USA.
Clinicoecon Outcomes Res ; 12: 625-633, 2020.
Article em En | MEDLINE | ID: mdl-33149635

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article